Use the fields below to perform an advanced search of The Chronicle's archives. This will return articles, images, and multimedia relevant to your query. You can also try a Basic search
31 items found for your search. If no results were found please broaden your search.
A group of Duke chemists are in the process of refining a new diversity-based method to serve as a starting point for drug discovery and research. The researchers, led by Eric Toone, professor of chemistry, hope to establish a facility in the Triangle to house this process.
Approximately 8.2 million Americans and 60,000 North Carolinians suffer from Type 2 diabetes, a metabolic disorder involving insulin irregularities and high blood glucose levels. Scientists are now one step closer to solving the mystery of this disease with the recent discovery of a gene that could be responsible for up to 20 percent of Type 2 cases.
This is the second in a three-part series about health and science issues in the 2004 election.
This is the last in a four-part series about the Institute for Genome Sciences and Policy.
This is the third in a four-part series about the Institute for Genome Sciences and Policy.
This is the second in a four-part series about the Institute for Genome Sciences and Policy.
This is the first in a four-part series about the Institute for Genome Sciences and Policy.
To Alan Rosenkranz, a Florida native, it was a miracle that he could take his 8-year-old granddaughter on a trip to New York City this past summer. Doctors did not have much hope for Rosenkranz’s recovery from renal cell cancer. But Duke University Health System doctors came to Rosenkranz’s rescue with a new treatment for his cancer of the kidneys—vaccine therapy, which the Food and Drug Administration approved just a few months ago.
Eleven of the world�s top medical journals are making the reporting of all clinical trial results a condition of publication in an attempt to remedy concerns about the selective disclosure of experimental data by pharmaceutical companies.
In an effort to address some of the most pressing ethical, legal and social questions that have developed along with recent advances in genetic and genome science, the National Human Genome Research Institute, part of the National Institutes of Health, has awarded the University a $4.8 million grant to establish the Center for Public Genomics.
The Institute for Genome Sciences and Policy has recruited Dr. Geoffrey Ginsburg to direct its Center for Genomic Medicine. The Center�s mission is to translate personalized medicine research, which has become a strong focus within the realm of science and medicine at the University, into clinical realities.
As Duke University Health System begins a new year of health care, research and education, Molly O’Neill, chief strategic planning officer, vice president for business development and vice chancellor for Medical Center integrated planning, will work to streamline the future vision of DUHS by combining roles previously held by several people.
School-based substance use prevention programs are a key tool in delivering anti-drug messages to youngsters and adolescents. Although most of the current programs across the nation focus solely on prevention, they tend to lack effectiveness due to content and teachers’ inability to convey the urgency of the issue at hand.
A diagnosis of cancer can be devastating--and so can its treatments. But imagine going deep sea diving, solving the mystery of the Titanic, touring an art museum or exploring ancient worlds instead of concentrating on chemotherapy and its side effects.
This is the first in a series of articles examining current research trends.
As the nationwide nursing shortage continues to be a chief concern among medical and health centers, Duke's School of Nursing has leaped into action. Its nurse anesthesia program, which is entering its fourth year, is attracting potential nurse anesthetists from all around the country with its unique educational and clinical approach.
____simple_html_dom__voku__html_wrapper____>One year ago this past Saturday, Jésica Santillán died at Duke University Hospital after a second heart-lung transplant that was intended to correct an initial organ transplantation incompatible with her blood type. Although investigations ultimately determined that a failure to communicate basic information between more than a dozen people across multiple organizations was responsible for the Santillán incident, members of the medical community continue to reflect on the events surrounding her death.
As the fall semester came to a close Dec. 13, the University's School of Nursing proudly graduated its first class of 38 accelerated Bachelor of Science students. The 16-month long program is designed for those who have a bachelor's degree in another field--ranging from mechanical engineering to English--but have decided to enter the field of nursing.
One of the global leaders in the genetics of neurodegenerative diseases Margaret Pericak-Vance, director of the Center for Human Genetics at Duke University, has led her team in the discovery of new genes involved in Alzheimer's and Parkinson's diseases.
A rapidly-developing field across the country and at Duke, toxicogenomics holds the key in identifying the genetic and environmental basis for many diseases.
